OverviewSuggest Edit

The Cronos Group (formerly PharmaCan Capital) is a company engaged in distributing medical cannabis. Its services include importing, exporting and supplying of narcotic drugs for medical purposes in the European Union, enabling medicine manufacturing companies and patients to get rare drugs easily.

TypePublic
Founded2013
HQToronto, CA
Websitethecronosgroup.com

Latest Updates

Employees (est.) (Dec 2018)37(+185%)
Job Openings45
Share Price (Oct 2019)$8.4

Key People/Management at Cronos Group

Michael Gorenstein

Michael Gorenstein

CEO

Cronos Group Office Locations

Cronos Group has an office in Toronto
Toronto, CA (HQ)
320 720 King St W
Show all (1)

Cronos Group Financials and Metrics

Cronos Group Revenue

Market capitalization (16-Oct-2019)

2.9b

Closing stock price (16-Oct-2019)

8.4
Cronos Group's current market capitalization is $2.9 b.
Show all financial metrics

Cronos Group Online and Social Media Presence

Embed Graph

Cronos Group News and Updates

Thinking about buying stock in Canopy Growth Corp, Cronos Group, Hepion Pharmaceuticals, Morgan Stanley, or Tilray?

NEW YORK, Oct. 17, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CGC, CRON, HEPA, MS, and TLRY. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Cronos Group Issues Statement on Separately Announced IPO of Cronos Australia

TORONTO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today noted the separately announced AUD$20 million initial public offering of Cronos Australia Limited (“Cronos Australia”). Under the offering, Cronos Australia is expected t…

Cronos Group Inc. to Hold Third Quarter 2019 Earnings Conference Call

TORONTO, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will announce its financial results for the third quarter ended September 31, 2019 and hold its Third Quarter 2019 Earnings Conference Call on Tuesday, November 12, 2019 at 8:3…

Thinking about buying stock in Alibaba, Canopy Growth, Cronos Group, Intel, or Nike?

NEW YORK, Oct. 8, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BABA, CGC, CRON, INTC, and NKE. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Alibaba, Canopy Growth, Cronos Group, Intel, or Nike?

NEW YORK, Oct. 8, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BABA, CGC, CRON, INTC, and NKE. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Apple, Canopy Growth, Cronos Group, PepsiCo, or Viveve Medical?

NEW YORK, Oct. 1, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, CGC, CRON, PEP, and VIVE. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
Show more

Cronos Group Frequently Asked Questions

  • When was Cronos Group founded?

    Cronos Group was founded in 2013.

  • Who are Cronos Group key executives?

    Cronos Group's key executives are Michael Gorenstein.

  • How many employees does Cronos Group have?

    Cronos Group has 37 employees.

  • Who are Cronos Group competitors?

    Competitors of Cronos Group include Tilray, Mylan and Canopy Growth.

  • Where is Cronos Group headquarters?

    Cronos Group headquarters is located at 320 720 King St W, Toronto.

  • Where are Cronos Group offices?

    Cronos Group has an office in Toronto.

  • How many offices does Cronos Group have?

    Cronos Group has 1 office.